Novel Transplant and Post-Transplant Options in ALL

被引：0

作者：

Logan, Aaron C. ^{[1
]}

机构：

[1] Univ Calif San Francisco, 505 Parnassus Ave,Box 1270, San Francisco, CA 94143 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

ALL; acute lymphoblastic leukemia; allogeneic hematopoietic cell transplant; measurable residual disease; blinatumomab; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; CORD-BLOOD TRANSPLANTATION; LONG-TERM; HIGH-RISK; ADULT; BLINATUMOMAB; THERAPY; RELAPSE;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EXABS-104-

引用

页码：S7 / S9

页数：3

共 20 条

[1]

Akabane H, 2020, CLIN ADV HEMATOL ONC, V18, P413

[2] Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival [J].

Bachanova, Veronika ;

Burke, Michael J. ;

Yohe, Sophia ;

Cao, Qing ;

Sandhu, Karamjeet ;

Singleton, Timothy P. ;

Brunstein, Claudio G. ;

Wagner, John E. ;

Verneris, Michael R. ;

Weisdorf, Daniel J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) :963-968

[3] Impact of detectable measurable residual disease on umbilical cord blood transplantation [J].

Baron, Frederic ;

Labopin, Myriam ;

Ruggeri, Annalisa ;

Sierra, Jorge ;

Robinson, Stephen ;

Labussiere-Wallet, Helene ;

Potter, Michael ;

Ribera, Josep-Maria ;

Deconinck, Eric ;

Rambaldi, Alessandro ;

Rohrlich, Pierre-Simon ;

de Revel, Thierry ;

Gluckman, Eliane ;

Nagler, Arnon ;

Mohty, Mohamad .

AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) :1057-1065

[4] Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia AMeta-analysis [J].

Berry, Donald A. ;

Zhou, Shouhao ;

Higley, Howard ;

Mukundan, Lata ;

Fu, Shuangshuang ;

Reaman, Gregory H. ;

Wood, Brent L. ;

Kelloff, Gary J. ;

Jessup, J. Milburn ;

Radich, Jerald P. .

JAMA ONCOLOGY, 2017, 3 (07)

[5] Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment [J].

Demosthenous, Christos ;

Lalayanni, Chrysavgi ;

Iskas, Michalis ;

Douka, Vassiliki ;

Pastelli, Nikoleta ;

Anagnostopoulos, Achilles .

CURRENT PROBLEMS IN CANCER, 2019, 43 (03) :222-227

[6] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia [J].

Goekbuget, Nicola ;

Dombret, Herve ;

Bonifacio, Massimiliano ;

Reichle, Albrecht ;

Graux, Carlos ;

Faul, Christoph ;

Diedrich, Helmut ;

Topp, Max S. ;

Brueggemann, Monika ;

Horst, Heinz-August ;

Havelange, Violaine ;

Stieglmaier, Julia ;

Wessels, Hendrik ;

Haddad, Vincent ;

Benjamin, Jonathan E. ;

Zugmaier, Gerhard ;

Nagorsen, Dirk ;

Bargou, Ralf C. .

BLOOD, 2018, 131 (14) :1522-1531

[7] HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis [J].

Gooptu, Mahasweta ;

Romee, Rizwan ;

St Martin, Andrew ;

Arora, Mukta ;

Al Malki, Monzr ;

Antin, Joseph H. ;

Bredeson, Christopher N. ;

Brunstein, Claudio G. ;

Chhabra, Saurabh ;

Fuchs, Ephraim J. ;

Ghosh, Nilanjan ;

Grunwald, Michael R. ;

Kanakry, Christopher G. ;

Kekre, Natasha ;

McGuirk, Jospeh P. ;

McNiece, Ian K. ;

Mehta, Rohtesh S. ;

Mielcarek, Marco ;

Milano, Fillipo ;

Modi, Dipenkumar ;

Reshef, Ran ;

Solomon, Scott R. ;

Schroeder, Mark A. ;

Waller, Edmund K. ;

Inamoto, Yoshiro ;

Soiffer, Robert J. ;

Eapen, Mary .

BLOOD, 2021, 138 (03) :273-282

[8] Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study [J].

Jabbour, Elias ;

Short, Nicholas J. ;

Ravandi, Farhad ;

Huang, Xuelin ;

Daver, Naval ;

DiNardo, Courtney D. ;

Konopleva, Marina ;

Pemmaraju, Naveen ;

Wierda, William ;

Garcia-Manero, Guillermo ;

Sasaki, Koji ;

Cortes, Jorge ;

Garris, Rebecca ;

Khoury, Joseph D. ;

Jorgensen, Jeffrey ;

Jain, Nitin ;

Alvarez, Joie ;

O'Brien, Susan ;

Kantarjian, Hagop .

LANCET HAEMATOLOGY, 2018, 5 (12) :E618-E627

[9]

Kebriaei P, 2020, BIOL BLOOD MARROW TR, V26, pS102

[10] Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long Term Study Results [J].

Kebriaei, Partow ;

Bassett, Roland ;

Lyons, Genevieve ;

Valdez, Ben ;

Ledesma, Celina ;

Rondon, Gabriela ;

Oran, Betul ;

Ciurea, Stefan ;

Alousi, Amin ;

Popat, Uday ;

Patel, Krina ;

Ahmed, Sairah ;

Olson, Amanda ;

Bashir, Qaiser ;

Shah, Nina ;

Jones, Roy ;

Marin, David ;

Rezvani, Katayoun ;

Nieto, Yago ;

Khouri, Issa ;

Qazilbash, Muzaffar ;

Hosing, Chitra ;

Shpall, Elizabeth ;

Champlin, Richard E. ;

Andersson, Borje S. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) :285-292

← 1 2 →